Year archive

AIOBIO Co., Ltd. — 2024 filings

All 16 regulatory filings released by AIOBIO Co., Ltd. (447690) in 2024, sourced directly from the official regulator.

16 Filings

2024 Period

2024 filings (16)

Filing	Released	Lang
주주명부폐쇄기간또는기준일설정 Regulatory Filings	2024-12-11	Korean
기업설명회(IR)개최결과 Regulatory Filings	2024-11-15	Korean
기타주요경영사항(자율공시) (미국식품의약국(FDA) 의료기기(2등급) 품목허가 취득 (치아우식증 진단 보조 장비)) Regulatory Filings	2024-09-05	Korean
[기재정정]주요사항보고서(전환사채권발행결정) Share Issue/Capital Change	2024-07-02	Korean
주요사항보고서(전환사채권발행결정) Capital/Financing Update	2024-07-01	Korean
증권발행결과(자율공시) (제1회차 CB) Share Issue/Capital Change	2024-07-01	Korean
기업설명회(IR)개최결과 Report Publication Announcement	2024-07-01	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-06-28	Korean
[기재정정]감사보고서제출 Audit Report / Information FY 2023	2024-04-24	Korean
[기재정정]사업보고서 (2023.12) Annual Report FY 2023	2024-04-24	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2024-03-27	Korean
[첨부추가]감사보고서제출 Audit Report / Information FY 2023	2024-03-19	Korean
[첨부추가]사업보고서 (2023.12) Audit Report / Information FY 2023	2024-03-19	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2024-03-13	Korean
주주총회소집결의 AGM Information	2024-03-12	Korean
주주총회집중일개최사유신고 AGM Information	2024-03-12	Korean